Infliximab (intravitreal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Infliximab (intravitreal), covering 2015-12-03 to 2015-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study [Phase 1, Phase 2]